Our exhibitors
AXT Pty Ltd
AXT is Australia’s leading supplier of high technology scientific equipment for sample preparation and analysis for academic and industrial applications. Through our various distribution agreements with international renowned and recognised brands, we are uniquely placed to be able to offer complete and comprehensive solution packages from within our own product portfolios.
Celvivo
Celvivo is a Danish life sciences company that develops the ClinoStar platform for human-relevant 3D cell culture. It uses simulated microgravity and low shear to grow larger, more mature organoids, spheroids and tissues. Researchers use it in tissue engineering, regenerative medicine, disease modelling and drug discovery, and it supports the move towards New Approach Methodologies (NAMs).
Gelomics
Gelomics is an Australian biotechnology company developing biomaterials, instruments and digital tools for preclinical drug development, tissue engineering and advanced 3D cell culture models. The new LunaX™ Crosslinker independently controls visible-light crosslinking in every well, enabling multiple matrix stiffness conditions on a single plate. Gelomics Cloud connects online experiment design with instrument operation, reusable protocols and structured documentation.
Gesim Mbh
GeSiM develops and builds devices in the field of liquid handling, primarily for diagnostic applications. We are also experts in the field of microfluidics and build one of the most innovative bioprinters in the world. As a medium-sized company, we are active worldwide and always responsive to customer-specific solutions.
Guangzhou Trauer Biotechnology
Founded in 2002, we are a national high-tech enterprise integrating R&D, production and sales, specializing in bioactive collagen materials, medical devices and bio-skincare products.
Pioneering China’s collagen dressing industry, we hold China’s first collagen dressing medical device registration certificate and have developed NMPA Class III collagen sponge. Certified with ISO 13485, ISO 22442 and EU TSE-CEP, with US FDA MAF submission completed, we provide medical-grade collagen materials and customized solutions for global partners in medical devices, biopharmaceuticals, aesthetic medicine and functional skincare. With R&D centers in China and the USA, we strive to become the global leader in medical collagen.
Izon Science
Izon Science delivers precision tools for nanoparticle isolation and characterisation, from extracellular vesicles (EVs) and lipid nanoparticles (LNPs) to viral vectors. Our qEV size exclusion chromatography columns set the benchmark for reproducible, high-purity EV isolation and now support LNP workflows. The Exoid and Pulsoid measure particles one at a time, giving high-resolution measurements of size, charge and concentration. These insights help shape isolation protocols and assess drug stability. Our scalable bioprocessing solutions, from automated large-volume and high-throughput processing to tangential flow filtration, take researchers and manufacturers from discovery to GMP-ready production. Our customers are advancing mRNA/LNP therapeutics, EV-based diagnostics and regenerative medicine.
Kraken Regen by Maverick Bio
Founded on a commitment to advancing scientific discovery, Kraken Regen is where biology meets performance. An incubated venture of Maverick Bio, we combine decades of biomaterials expertise with fresh thinking to create high-performance materials for regenerative medicine research. Kraken Collagen Hydrogel gives cells a naturally derived 3D environment without compromising on stability, consistency or handling - helping researchers break new ground in regenerative medicine.
University of Otago - Centre for Bioengineering & Translational Health Technologies
Bioengineering and HealthTech innovation is shaping the future of Aotearoa-NZ’s medical technologies by driving deep-tech R&D establishing new high-value, knowledge-intensive industries.
The Centre for Bioengineering & Translational Health Technologies at the University of Otago drives Bioengineering and translational HealthTech innovation. We are addressing global health issues by bringing together multidisciplinary students and early/mid-career researchers. Enhancing UO’s global reputation and revenue by integrating advanced technology and clinical partnerships, translating research into clinical solutions and commercial startups. We focus on innovative, sustainable, and environmentally sensitive HealthTech, employing digital health, diagnostics, and biomanufacturing to reduce waste and carbon footprint. Our research partnerships with Māori co-develop culturally distinctive health technologies, improving health outcomes in NZ.